Ketamine-induced hepatoprotection: The role of heme oxygenase-1

James W. Suliburk, Jeremy L. Ward, Kenneth S. Helmer, Sasha D. Adams, Brian S. Zuckerbraun, David W. Mercer

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Lipopolysaccharide (LPS) causes hepatic injury that is mediated, in part, by upregulation of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Ketamine has been shown to prevent these effects. Because upregulation of heme oxygenase-1 (HO-1) has hepatoprotective effects, as does carbon monoxide (CO), an end product of the HO-1 catalytic reaction, we examined the effects of HO-1 inhibition on ketamine-induced hepatoprotection and assessed whether CO could attenuate LPS-induced hepatic injury. One group of rats received ketamine (70 mg/kg ip) or saline concurrently with either the HO-1 inhibitor tin protoporphyrin IX (50 μmol/kg ip) or saline. Another group of rats received inhalational CO (250 ppm over 1 h) or room air. All rats were given LPS (20 mg/kg ip) or saline 1 h later and euthanized 5 h after LPS or saline. Liver was collected for iNOS, COX-2, and HO-1 (Western blot), NF-κB and PPAR-γ analysis (EMSA), and iNOS and COX-2 mRNA analysis (RT-PCR). Serum was collected to measure alanine aminotransferase as an index of hepatocellular injury. HO-1 inhibition attenuated ketamine-induced hepatoprotection and downregulation of iNOS and COX-2 protein. CO prevented LPS-induced hepatic injury and upregulation of iNOS and COX-2 proteins. Although CO abolished the ability of LPS to diminish PPAR-γ activity, it enhanced NF-κB activity. These data suggest that the hepatoprotective effects of ketamine are mediated primarily by HO-1 and its end product CO.

Original languageEnglish (US)
Pages (from-to)G1360-G1369
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume296
Issue number6
DOIs
StatePublished - Jun 1 2009

Fingerprint

Heme Oxygenase-1
Ketamine
Carbon Monoxide
Nitric Oxide Synthase Type II
Lipopolysaccharides
Cyclooxygenase 2
Peroxisome Proliferator-Activated Receptors
Up-Regulation
Liver
Wounds and Injuries
Alanine Transaminase
Proteins
Down-Regulation
Western Blotting
Air
Polymerase Chain Reaction
Messenger RNA
Serum

Keywords

  • Carbon monoxide
  • Cyclooxygenase-2
  • Inducible nitric oxide synthase
  • Lipopolysaccharide
  • Tin protoporphyrin IX

ASJC Scopus subject areas

  • Physiology
  • Hepatology
  • Gastroenterology
  • Physiology (medical)

Cite this

Ketamine-induced hepatoprotection : The role of heme oxygenase-1. / Suliburk, James W.; Ward, Jeremy L.; Helmer, Kenneth S.; Adams, Sasha D.; Zuckerbraun, Brian S.; Mercer, David W.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 296, No. 6, 01.06.2009, p. G1360-G1369.

Research output: Contribution to journalArticle

Suliburk, James W. ; Ward, Jeremy L. ; Helmer, Kenneth S. ; Adams, Sasha D. ; Zuckerbraun, Brian S. ; Mercer, David W. / Ketamine-induced hepatoprotection : The role of heme oxygenase-1. In: American Journal of Physiology - Gastrointestinal and Liver Physiology. 2009 ; Vol. 296, No. 6. pp. G1360-G1369.
@article{07bacc1346894433bcfaf48a833b85e1,
title = "Ketamine-induced hepatoprotection: The role of heme oxygenase-1",
abstract = "Lipopolysaccharide (LPS) causes hepatic injury that is mediated, in part, by upregulation of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Ketamine has been shown to prevent these effects. Because upregulation of heme oxygenase-1 (HO-1) has hepatoprotective effects, as does carbon monoxide (CO), an end product of the HO-1 catalytic reaction, we examined the effects of HO-1 inhibition on ketamine-induced hepatoprotection and assessed whether CO could attenuate LPS-induced hepatic injury. One group of rats received ketamine (70 mg/kg ip) or saline concurrently with either the HO-1 inhibitor tin protoporphyrin IX (50 μmol/kg ip) or saline. Another group of rats received inhalational CO (250 ppm over 1 h) or room air. All rats were given LPS (20 mg/kg ip) or saline 1 h later and euthanized 5 h after LPS or saline. Liver was collected for iNOS, COX-2, and HO-1 (Western blot), NF-κB and PPAR-γ analysis (EMSA), and iNOS and COX-2 mRNA analysis (RT-PCR). Serum was collected to measure alanine aminotransferase as an index of hepatocellular injury. HO-1 inhibition attenuated ketamine-induced hepatoprotection and downregulation of iNOS and COX-2 protein. CO prevented LPS-induced hepatic injury and upregulation of iNOS and COX-2 proteins. Although CO abolished the ability of LPS to diminish PPAR-γ activity, it enhanced NF-κB activity. These data suggest that the hepatoprotective effects of ketamine are mediated primarily by HO-1 and its end product CO.",
keywords = "Carbon monoxide, Cyclooxygenase-2, Inducible nitric oxide synthase, Lipopolysaccharide, Tin protoporphyrin IX",
author = "Suliburk, {James W.} and Ward, {Jeremy L.} and Helmer, {Kenneth S.} and Adams, {Sasha D.} and Zuckerbraun, {Brian S.} and Mercer, {David W.}",
year = "2009",
month = "6",
day = "1",
doi = "10.1152/ajpgi.00038.2009",
language = "English (US)",
volume = "296",
pages = "G1360--G1369",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - Ketamine-induced hepatoprotection

T2 - The role of heme oxygenase-1

AU - Suliburk, James W.

AU - Ward, Jeremy L.

AU - Helmer, Kenneth S.

AU - Adams, Sasha D.

AU - Zuckerbraun, Brian S.

AU - Mercer, David W.

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Lipopolysaccharide (LPS) causes hepatic injury that is mediated, in part, by upregulation of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Ketamine has been shown to prevent these effects. Because upregulation of heme oxygenase-1 (HO-1) has hepatoprotective effects, as does carbon monoxide (CO), an end product of the HO-1 catalytic reaction, we examined the effects of HO-1 inhibition on ketamine-induced hepatoprotection and assessed whether CO could attenuate LPS-induced hepatic injury. One group of rats received ketamine (70 mg/kg ip) or saline concurrently with either the HO-1 inhibitor tin protoporphyrin IX (50 μmol/kg ip) or saline. Another group of rats received inhalational CO (250 ppm over 1 h) or room air. All rats were given LPS (20 mg/kg ip) or saline 1 h later and euthanized 5 h after LPS or saline. Liver was collected for iNOS, COX-2, and HO-1 (Western blot), NF-κB and PPAR-γ analysis (EMSA), and iNOS and COX-2 mRNA analysis (RT-PCR). Serum was collected to measure alanine aminotransferase as an index of hepatocellular injury. HO-1 inhibition attenuated ketamine-induced hepatoprotection and downregulation of iNOS and COX-2 protein. CO prevented LPS-induced hepatic injury and upregulation of iNOS and COX-2 proteins. Although CO abolished the ability of LPS to diminish PPAR-γ activity, it enhanced NF-κB activity. These data suggest that the hepatoprotective effects of ketamine are mediated primarily by HO-1 and its end product CO.

AB - Lipopolysaccharide (LPS) causes hepatic injury that is mediated, in part, by upregulation of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Ketamine has been shown to prevent these effects. Because upregulation of heme oxygenase-1 (HO-1) has hepatoprotective effects, as does carbon monoxide (CO), an end product of the HO-1 catalytic reaction, we examined the effects of HO-1 inhibition on ketamine-induced hepatoprotection and assessed whether CO could attenuate LPS-induced hepatic injury. One group of rats received ketamine (70 mg/kg ip) or saline concurrently with either the HO-1 inhibitor tin protoporphyrin IX (50 μmol/kg ip) or saline. Another group of rats received inhalational CO (250 ppm over 1 h) or room air. All rats were given LPS (20 mg/kg ip) or saline 1 h later and euthanized 5 h after LPS or saline. Liver was collected for iNOS, COX-2, and HO-1 (Western blot), NF-κB and PPAR-γ analysis (EMSA), and iNOS and COX-2 mRNA analysis (RT-PCR). Serum was collected to measure alanine aminotransferase as an index of hepatocellular injury. HO-1 inhibition attenuated ketamine-induced hepatoprotection and downregulation of iNOS and COX-2 protein. CO prevented LPS-induced hepatic injury and upregulation of iNOS and COX-2 proteins. Although CO abolished the ability of LPS to diminish PPAR-γ activity, it enhanced NF-κB activity. These data suggest that the hepatoprotective effects of ketamine are mediated primarily by HO-1 and its end product CO.

KW - Carbon monoxide

KW - Cyclooxygenase-2

KW - Inducible nitric oxide synthase

KW - Lipopolysaccharide

KW - Tin protoporphyrin IX

UR - http://www.scopus.com/inward/record.url?scp=67049132811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67049132811&partnerID=8YFLogxK

U2 - 10.1152/ajpgi.00038.2009

DO - 10.1152/ajpgi.00038.2009

M3 - Article

C2 - 19372106

AN - SCOPUS:67049132811

VL - 296

SP - G1360-G1369

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 6

ER -